Clinical Trial Update: Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares weekly Paclitaxel with and without Carboplatin in early breast cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Tao OUYANG | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED